Which is better, DEO or PGHH.BO?

On the Buffett-Fit framework, Procter & Gamble Hygiene and Health Care Limited (PGHH.BO) currently grades higher than DEO — 78/100 (B grade) vs 60/100 (C). That said, "better" depends on which framework you trust — DEO wins on none; PGHH.BO wins on Warren Buffett, Benjamin Graham, Philip Fisher, Peter Lynch, Joel Greenblatt, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy DEO or PGHH.BO?

This page is an educational comparison, not investment advice. Both DEO and PGHH.BO are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is DEO better than PGHH.BO for value investing?

On the Buffett-style value-investing framework, PGHH.BO currently grades higher — 78/100 vs 60/100, a 18-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between DEO and PGHH.BO on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). DEO currently scores 60/100 (C grade); PGHH.BO scores 78/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, DEO or PGHH.BO?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. DEO and PGHH.BO are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, DEO or PGHH.BO?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are DEO and PGHH.BO both Consumer Defensive stocks?

Yes — both Diageo plc (DEO) and Procter & Gamble Hygiene and Health Care Limited (PGHH.BO) operate in the Consumer Defensive sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this DEO vs PGHH.BO comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Diageo

DEO$46.45BConsumer Staples Market cap, Sector

Procter & Gamble Hygiene and Health Care Limited

PGHH.BO$284.92BConsumer Staples Market cap, Sector

Overall winner

Procter & Gamble Hygiene and Health Care Limited

DEO 07 PGHH.BO

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

Fit scores by strategy

DEO0wins

7winsPGHH.BO

Warren Buffett

60C

B78

Benjamin Graham

72B

B76

Philip Fisher

49D

B76

Peter Lynch

37F

C63

Joel Greenblatt

33F

A85

Charlie Munger

60C

B84

Terry Smith

59D

B83

Side-by-side metrics

Metric	DEO	PGHH.BO
Market cap	$46.45B	$284.92B Winner
P/E (TTM)	Winner: 19.8x	34.2x
EV/EBIT	Winner: 16.2x	24.4x
ROIC (TTM)	9.41%	116.93% Winner
Gross margin	59.68%	63.44% Winner
Net margin	12.18%	20.0% Winner
Revenue CAGR 5y	Winner: 12.29%	4.13%
EPS CAGR 5y	-1.8%	14.16% Winner
Debt / Equity	2.1x	0.0x Winner
Dividend yield	3.88%	-

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

DEO leads on

Revenue CAGR 5y12.29%vs 4.13%+66%
P/E (TTM)19.8xvs 34.2x+42%
EV/EBIT16.2xvs 24.4x+34%

PGHH.BO leads on

EPS CAGR 5y14.16%vs -1.8%+113%
Debt / Equity0.0xvs 2.1x+100%
ROIC (TTM)116.93%vs 9.41%+92%
Market cap$284.92Bvs $46.45B+84%

More like DEO

DEO vs 278470.KS DEO vs COLPAL.BO DEO vs 9633.HK DEO vs GILLETTE.NS

More like PGHH.BO

PGHH.BO vs 278470.KS PGHH.BO vs COLPAL.BO PGHH.BO vs 9633.HK PGHH.BO vs GILLETTE.NS

Read the full Buffett-Brain analysis for DEO Read the full Buffett-Brain analysis for PGHH.BO

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Side-by-side metrics

Metric	DEO	PGHH.BO
Market cap	$46.45B	$284.92B Winner
P/E (TTM)	Winner: 19.8x	34.2x
EV/EBIT	Winner: 16.2x	24.4x
ROIC (TTM)	9.41%	116.93% Winner
Gross margin	59.68%	63.44% Winner
Net margin	12.18%	20.0% Winner
Revenue CAGR 5y	Winner: 12.29%	4.13%
EPS CAGR 5y	-1.8%	14.16% Winner
Debt / Equity	2.1x	0.0x Winner
Dividend yield	3.88%	-

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

DEO leads on

Revenue CAGR 5y12.29%vs 4.13%+66%
P/E (TTM)19.8xvs 34.2x+42%
EV/EBIT16.2xvs 24.4x+34%

PGHH.BO leads on

EPS CAGR 5y14.16%vs -1.8%+113%
Debt / Equity0.0xvs 2.1x+100%
ROIC (TTM)116.93%vs 9.41%+92%
Market cap$284.92Bvs $46.45B+84%